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Introduction
The newly published 2015 World Health Organization 
(WHO) classification of lung tumors reclassified squamous 
cell carcinomas (SCC) into keratinizing, nonkeratinizing, 
and basaloid subtypes1, similar to the 2005 Head and Neck 
WHO Classification of nasopharyngeal carcinomas. Typically, 
keratinization implies lung SCC, although in the absence of 
unequivocal keratinization, immunohistochemistry is usually 
required to distinguish nonkeratinizing SCC from adenocarci-
noma. Similar to the head and neck cancer classification, the 
new lung SCC classification was upgraded to address these 
pathological issues2. However, the prognostic or other clini-
cal significance of this new lung SCC subtype classification is 
unclear, although recent studies of head and neck cancer have 
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revealed that compared to the non-keratinizing subtype, the 
keratinizing subtype is associated with a poorer prognosis3,4. 
In contrast, studies of the relationship between the keratiniz-
ing subtype and prognosis in lung SCC are rare, and one such 
study reported that the presence of keratinization was not a 
significant prognostic factor5.
According to previous literature, keratinization is accom-
panied by apoptosis and is ultimately associated with tumor 
progression in patients with esophageal SCC6. The expression 
of B-cell lymphoma (Bcl)-xL, an oncoprotein involved in lung 
SCC tumorigenesis, is known to correlate with apoptosis7-9; 
furthermore, deactivation of the tumorigenic mammalian 
target of rapamycin (mTOR) signaling pathway, which plays a 
key role in regulating cellular proliferation, survival, and angio-
genesis, also affects apoptosis in lung cancers10-13. These key 
apoptotic factors might correlate with keratinization and thus 
might affect prognosis. However, potential direct correlations 
of keratinization with the mTOR pathway and Bcl-xL expres-
sion have not been studied in lung SCC.
In the present study, we aimed to characterize the keratin-
izing and nonkeratinizing subtypes of lung SCC and confirm 
the effects of keratinization on overall survival (OS). In addi-
tion, we aimed to investigate correlations of keratinization 
with mTOR pathway activation and Bcl-xL expression.
Materials and Methods
1. Patients
Eighty-one patients who underwent surgical treatment of 
lung SCC between 1993 and 2016 were randomly selected 
from the Severance Hospital (Seoul, Korea) lung cancer data-
base. To obtain clinical data, we retrospectively reviewed the 
patients’ electronic medical records. Tumor stage was re-eval-
uated according to the seventh edition of the American Joint 
Committee on Cancer TNM Staging Manual14. This study was 
approved by the Institutional Review Board (IRB) of Sever-
ance Hospital (No. 3-2016-0019).
2. Histologic evaluation
All tissue slides were subjected to hematoxylin and eo-
sin staining and evaluated for the presence of the following 
recently identified poor prognostic factors: tumor budding, 
single cell invasion, and large nuclei5. Initially, the entire tumor 
set was scanned at ×100 magnification and subjected to a 
detailed review. First, tumor budding, or the presence of small 
tumor nests comprising fewer than five tumor cells, were 
counted in 10 high-power fields (HPFs) at ×200 magnification. 
We defined a high grade of tumor budding as more than eight 
tumor budding events per 10 HPFs (Figure 1A, B). Single cell 
Figure 1. Histologic parameters and patterns of keratinization applied in this study. Tumor budding is observed along tumor edge (A); this is 
defined as the presence of structures comprising fewer than five tumor cells (arrowheads) at higher magnification (B). Single cell invasion (C) 
and large nuclei (cancer cell nucleus >4 times than that of a small lymphocyte) (D), nonkeratinization (entire tumor area, <5% keratinization) 
(E), cytoplasmic keratinization (F), keratin pearl (G), and layered keratinization (H) (H&E stain; A, ×40; B–D, ×400; E–H, ×200).
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invasion was also evaluated at ×200 magnification (Figure 1C), 
and nuclear features were assessed at ×400 magnification. We 
calculated the average nuclear diameter of at least 100 tumor 
cells in at least three HPFs per sample. A large nucleus was 
defined as a diameter greater than that of four small lympho-
cytes (Figure 1D).
The keratinization grade was determined, and tumors were 
classified accordingly as the keratinizing subtype, defined as 
a keratinizing pattern comprising ≥5% of the entire tumor, or 
the nonkeratinizing subtype, defined as a keratinizing pattern 
comprising <5% of the tumor (Figure 1E). Subsequently, the 
keratinization grades were refined to nonkeratinization (<5%) 
and low (5%–20%), moderate (20%–50%), or severe (>50% of 
the entire tumor) keratinization, similar to the classification 
used for head and neck cancers15. The keratinization patterns 
included cytoplasmic keratinization (Figure 1F), keratin pearl 
(Figure 1G), and layered keratinization (Figure 1H). All histo-
logic parameters were evaluated independently by a patholo-
gist (Y.J.C.). 
3. Immunohistochemistry
To evaluate mTOR complex 1 (mTORC1) and Bcl-xL ex-
pression, immunohistochemistry (IHC) staining for pS6 and 
Bcl-xL proteins was performed using an EnVision+ system 
(Dako Corp., Carpinteria, CA, USA) according to the manu-
facturer’s instructions. Briefly, sections were deparaffinized, 
rehydrated, and subjected to antigen retrieval via microwave 
heating for 10 minutes. Sections were then immersed in a 
H2O2–phosphate-buffered saline solution prior to overnight 
incubation with primary anti-pS6 (1:400, Cell Signaling Tech-
nology, Danvers, MA, USA) or Bcl-xL antibodies (1:600, Cell 
Signaling Technology). Subsequently, the sections were in-
cubated with a peroxidase-labeled polymer for 1 hour at 4°C. 
IHC staining was scored independently at ×200 magnification 
by Y.J.C. and S.H.K., who were blinded to the clinicopathologi-
cal data. A semiquantitative evaluation of pS6 and Bcl-xL was 
performed according to the method described in a previous 
study16. The staining intensity was classified as 0 (negative), 
1 (trace), 2 (moderate), or 3 (strong), and the frequency of 
positive cells was classified as 0 (<10%), 1 (10%–50%), 2 (50%–
80%), or 3 (>80%). The expression score was determined as 
the product of the staining intensity and frequency of positive 
cells. 
4. Statistical analysis
Associations between categorical variables were analyzed 
using the chi-square test; this test was also used to assess the 
linear correlation trend of the keratinization grade with IHC 
scoring. Disease-free survival (DFS) and OS were estimated 
using the Kaplan-Meier method, and associations between 
factors and survival outcomes (OS) were analyzed using the 
log-rank test. The Cox proportional hazards model was used 
for multivariate analyses. SPSS version 18.0 (SPSS Inc., Chi-
cago, IL, USA) was used for all statistical analyses, and signifi-
cance was defined as a p-value of <0.05.
Results
1. Smoking correlates with the keratinization of lung 
SCC
Among the 81 patients enrolled in this study, 56 (69.1%) 
and 25 (30.9%) were classified as having the keratinizing and 
nonkeratinizing subtypes of lung SCC, respectively, as con-
firmed by a pathologic review of tumor slides. The average age 
of the subjects was 62.8±8.7 years (mean±standard deviation); 
77 (95.1%) were male, and the majority had stage T2 or T3 dis-
ease (84.0%). Among patients with the keratinizing subtype, 
21 (37.5%), 19 (33.9%), and 16 patients (28.6%) were classified 
as having low, moderate, and severe keratinization, respec-
tively. The keratinizing and nonkeratinizing groups did not dif-
fer significantly with respect to the distributions of age, sex, T-, 
N-, pStage, type of surgery, and adjuvant chemotherapy. How-
ever, most patients with the keratinizing subtype (98.0%) had 
a history of smoking, whereas never smokers (24.0%) were 
significantly more prevalent in the nonkeratinizing subtype 
group (Pearson’s R=0.262, p=0.008, chi-square test). In a sub-
group analysis of smokers, keratinization was more frequently 
observed among heavy smokers (i.e., ≥30 pack-year history of 
smoking) (p=0.012, chi-square test). This finding suggests that 
keratinization of lung SCC might be related to smoking (Table 
1). Other morphologic parameters, such as nuclear diameter, 
tumor budding, and single cell invasion at the tumor edge, 
were not found to correlate with the keratinization of lung 
SCC. 
2. mTORC1 and Bcl-xL expression did not correlate 
with lung SCC keratinization
Because mTOR signaling is known to regulate keratino-
cyte differentiation, we reviewed the relationship between 
keratinization and mTORC1 in 51 available lung SCC tissues, 
using pS6 expression as a surrogate marker. Among these 51 
cases, five (9.8%), 12 (23.5%), and 23 (45.1%) exhibited strong, 
moderate, and trace expression, respectively. An additional 11 
cases (21.6%) were negative for pS6. Viable tumors expressed 
pS6 beneath the shedding area, where keratinization initiates, 
regardless of keratinization subtype (Figure 2). However, the 
correlation between keratinization grade and pS6 expression 
failed to reach statistical significance (p=0.153, chi-square 
test). 
In tumors, keratinization is generated by the epithelial layer 
and is subsequently shed from the tumor margin by apopto-
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Table 1. Demographics and pathologic characteristics of patients with and without keratinization
Variable Nonkeratinization (n=25) Keratinization (n=56) Total (n=81) p-value
Age, yr 0.807
    ≤65 16 (64.0) 33 (58.9) 49 (60.5)
    >65 9 (36.0) 23 (41.1) 32 (39.5)
Sex 0.583
    Male 23 (92.0) 54 (96.4) 77 (95.1)
    Female 2 (8.0) 2 (3.6) 4 (4.9)
Smoking status 0.008
    Never smoker 6 (24.0) 1 (2.0) 7 (8.6)
    Former smoker 7 (28.0) 18 (35.3) 25 (30.9)
    Current smoker 12 (48.0) 32 (62.7) 44 (54.3)
    Unknown - - 5 (6.2)
Smoking pack-years 0.012
    <30 12 (48.0) 9 (17.6) 21 (27.6)
    ≥30 13 (52.0) 42 (82.4) 55 (72.4)
T classification 0.605
    T1 4 (16.0) 4 (7.1) 8 (9.9)
    T2 15 (60.0) 39 (69.6) 54 (66.7)
    T3 4 (16.0) 10 (17.9) 14 (17.3)
    T4 2 (8.0) 3 (5.4) 5 (6.2)
N classification 0.811
    N0 16 (64.0) 35 (62.5) 51 (63.0)
    N1 5 (20.0) 9 (16.1) 14 (17.3)
    N2 4 (16.0) 12 (21.4) 16 (19.8)
pStage 0.938
    pStage I 9 (36.0) 22 (39.3) 31 (38.3)
    pStage II 9 (36.0) 18 (32.1) 27 (33.3)
    pStage III 7 (28.0) 16 (28.6) 23 (28.4)
Type of surgery 0.806
    Lobectomy 16 (64.0) 32 (58.2) 48 (60.0)
    Pneumonectomy 9 (36.0) 23 (41.8) 32 (40.0)
Adjuvant chemotherapy >0.999 
    No 15 (60.0) 33 (58.9) 48 (59.3)
    Yes 10 (40.0) 23 (41.1) 33 (40.7)
Nuclear diameter 0.111
    Small 6 (31.6) 31 (55.4) 37 (49.3)
    Large 13 (68.4) 25 (44.6) 38 (50.7)
Tumor budding 0.493
    Low (<8/10 HPFs) 18 (90.0) 44 (80.0) 62 (82.7)
    High (≥8/10 HPFs) 2 (10.0) 11 (20.0) 13 (17.3)
Single cell invasion >0.999
    Absent 14 (73.7) 40 (72.7) 54 (73.0)
    Present 5 (26.3) 15 (27.3) 20 (27.0)
Values are presented as number (%).
HPFs: high-power fields.
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sis. Under a hypothesis that Bcl-xL, a key anti-apoptotic mole-
cule, might inhibit keratinization, we investigated the relation-
ship between keratinization and apoptosis in the keratinized 
area. Although we observed a negative correlation between 
Bcl-xL and tumor cell keratinization, this relationship did not 
reach statistical significance (Pearson’s R=–0.264, p=0.062, chi-
square test) (Figure 2).
3. Keratinization was associated with a poor clinical 
outcome in lung SCC
We next analyzed the clinical outcomes of lung SCC ac-
cording to keratinization. Although the keratinizing subtype 
was associated with a reduced DFS, this difference did not 
reach statistical significance (119.6 months vs. 122.7 months, 
p=0.459, log-rank test). However, the keratinizing subtype was 
associated with significantly shorter OS relative to the non-
keratinizing subtype (85.2 months vs. 135.7 months, p=0.010, 
log-rank test) (Figure 3).
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Figure 2. Relationship of keratinization (A–D, H&E stain, ×200) with the expression of pS6 ribosomal protein (Ser235/236; E–H, ×200) and 
Bcl-xL (I–L, ×200). Images represent nonkeratinization (A, E, I), cytoplasmic keratinization (B, F, J), keratin pearl (C, G, K), and layered kerati-
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In a univariate analysis, old age (p=0.039) and a history of 
smoking (p=0.036) were associated with a significantly short-
er OS. Among histologic parameters, a high tumor budding 
grade (p=0.037), presence of single cell invasion (p=0.006), 
and keratinizing subtype (p=0.013) were associated with a 
significantly poorer OS. To confirm keratinization as an inde-
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Figure 3. Disease-free survival (A) and overall survival (B) of patients with lung squamous cell carcinoma according to the keratinization sta-
tus (p-values were obtained using the log-rank test).
Table 2. Univariate and multivariate analyses of overall survival
Variable
Univariate analysis Multivariate analysis
HR 95% CI p-value HR 95% CI p-value
Age, yr ≤65 1 1
>65 1.799 1.031–3.319 0.039 2.154 1.150–4.035 0.017
Sex Male 1 1
Female 2.717 0.375–19.707 0.323 3.879 0.107–140.535 0.459
Smoking pack-year Never 1 1
Former 8.824 1.157–67.285 0.036 5.661 0.713–44.969 0.101
Current 6.062 0.825–44.534 0.077 3.729 0.491–28.310 0.203
pStage I 1 1
II 1.139 0.590–2.202 0.698 1.438 0.713–2.899 0.310
III 1.839 0.936–3.613 0.077 2.558 1.207–5.422 0.014
Adjuvant chemotherapy No 1
Yes 1.669 0.951–2.929 0.074
Nuclear diameter Small 1
Large 1.231 0.701–2.163 0.469
Tumor budding Low (<8/10 HPFs) 1
High (≥8/10 HPFs) 2.052 1.043–4.039 0.037
Single cell invasion Absent 1
Present 2.178 1.190–3.987 0.006
Keratinization grade Nonkeratinization 1 1
Keratinization 2.597 1.219–5.531 0.013 2.389 1.090–5.233 0.030
HR: hazard ratio; CI: confidence interval; HPFs: high-power fields.
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pendent prognostic factor for OS in lung SCC, we performed 
a multivariate analysis that included age, sex, smoking status, 
tumor stage, and keratinization. This analysis identified older 
age (>65 years; hazard ratio [HR], 2.154; 95% confidence inter-
val [CI], 1.150–4.035; p=0.017), advanced stage (stage III; HR, 
2.558; 95% CI, 1.207–5.422; p=0.014), and keratinization (HR, 
2.389; 95% CI, 1.090–5.233; p=0.030) as independent poor 
prognostic factors (Table 2).
Discussion
Keratins are epithelium-specific intermediate filament 
proteins that play a central role in maintaining the structural 
integrity of cells and are thought to be involved in cell differ-
entiation. Keratinocytes follow a unique program of terminal 
differentiation and apoptotic cell death, ultimately leading to 
the formation of the keratin layer17. For these reasons, keratini-
zation within tumors is considered a marker of well-differenti-
ated SCC of the head and neck, as well as of the lungs18,19.
Studies on head and neck SCC showed an association be-
tween the keratinizing subtype and a poorer OS (compared 
with the nonkeratinizing subtype)4,20,21. Although the under-
lying mechanism remains unclear, some researchers have 
indicated that keratinization is associated with poor prognosis 
in human papillomavirus-negative head and neck SCC22. Few 
studies have addressed OS with respect to keratinization in 
lung SCC. A recent study provided a key finding regarding 
the effects of keratinization on OS in this cancer type. Specifi-
cally, Xiao et al.23 demonstrated that IKKα is expressed at low 
and high levels in keratinizing and nonkeratinizing lung SCC, 
respectively. As a higher level of IKKα gene expression was 
found to correlate with good OS in patients with lung cancer, 
keratinizing lung SCC might lead to a poorer OS. Furthermore, 
among cases of nonkeratinizing lung SCC, the differentiated 
subtype correlated significantly with higher IKKα expression 
relative to the undifferentiated subtype; in other words, kera-
tinization of lung SCC might correlate with a poor OS, regard-
less of the differentiation status23. 
Smoking affects both the immunologic system and kera-
tinization process24; specifically, increased keratinization of 
the oral cavity is frequently observed in smokers because 
epithelial cells exposed to cigarette smoke defend themselves 
via elevated cytokeratin levels25-27. The present study therefore 
demonstrated similar effects of smoking on keratinization in 
the lungs.
mTOR and Bcl-xL, which are known to associate with kera-
tinocyte differentiation and apoptosis, respectively, were iden-
tified and analyzed in previous studies28,29. mTORC1 not only 
plays roles in mesenchymal cell differentiation processes such 
as adipogenesis, osteogenesis, and myogenesis, but is also 
involved in epithelial cell differentiation and integrity main-
tenance. Although the correlation between keratinization 
and mTORC1 activity (per the surrogate marker pS6) did not 
reach statistical significance in our study, we observed some 
overlap of positive pS6 staining with keratinization. Areas of 
keratinization initiation correlated negatively with the expres-
sion of the anti-apoptotic protein Bcl-xL, consistent with pre-
vious studies that demonstrated keratinization progression 
at the point of apoptotic pathway activation6. Accordingly, 
we suggest that apoptosis is inevitable during the process 
of keratinization; however, additional detailed studies of the 
underlying mechanisms should be conducted to confirm this 
hypothesis. 
We must note some limitations of the present study. For 
example, the number of study subjects was small. In addition, 
these subjects were limited to patients with surgically resect-
able lung SCC. A large cohort study that includes patients with 
unresectable lung SCC, as well as molecular profiling, will 
be needed to identify the detailed underlying mechanisms. 
Nevertheless, this study demonstrated that keratinization is a 
significantly poor prognostic factor in lung SCC, thus warrant-
ing large-scale studies to confirm this finding. 
Herein, we demonstrated the association of keratinization 
of lung SCC with a poor clinical outcome, in comparison with 
the nonkeratinization subtype. This outcome might result 
from the association of keratinization with smoking and the 
apoptotic features usually observed at the keratinizing site.
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